Back to Top

Paper Title

AI-DRIVEN PREDICTIVE MODELS IN HEALTHCARE: REDUCING TIME-TO-MARKET FOR CLINICAL APPLICATIONS

Authors

Pramod Kumar Voola
Pramod Kumar Voola
Punit Goel
Punit Goel
Krishna C Gangu
Krishna C Gangu
Arpit Jain
Arpit Jain
Pandi Kirupa Gopalakrishna Pandian
Pandi Kirupa Gopalakrishna Pandian

Keywords

  • predictive models
  • healthcare
  • clinical applications
  • time-to-market
  • personalized medicine
  • clinical trials
  • data privacy
  • machine learning
  • innovation
  • AI

Article Type

Research Article

Research Impact Tools

Issue

Volume : 01 | Issue : 02 | Page No : 118-129

Published On

November, 2021

Downloads

Abstract

Innovative clinical apps that improve patient outcomes and simplify procedures are in high demand in healthcare. In this field, AI has revolutionised prediction models that speed up clinical application development and implementation. This study examines how AI-driven predictive models reduce clinical application time-to-market, including their methods, obstacles, and advantages. AI-driven prediction models analyse massive volumes of healthcare data, including EHRs, genetic data, and clinical trial findings, using sophisticated algorithms and machine learning. These models may spot trends, forecast results, and provide clinical application design and optimisation insights. Healthcare organisations may accelerate market delivery by using AI to expedite development, decrease costs, and improve application accuracy. AI-driven prediction models may dramatically reduce clinical trial duration. Clinical trials with various testing and regulatory clearance steps are costly and time-consuming. AI models can anticipate patient responses, detect adverse effects, and optimise trial designs, speeding up the process and decreasing time-to-market. This helps pharmaceutical firms, healthcare providers, and patients by increasing access to novel treatments and therapies. Additionally, AI-driven prediction models provide personalised treatment by customising clinical applications to patient demands. AI models may predict therapy efficacy for distinct patient profiles by analysing patient-specific data, resulting in more focused and effective interventions. This personalised strategy improves treatment results and decreases unpleasant responses, speeding up development. AI-driven prediction models in healthcare face obstacles despite their potential advantages. Protecting sensitive patient data from breaches and abuse is crucial. Interoperability and regulatory compliance must also be considered when integrating AI models into healthcare systems. Predictive model accuracy and reliability are particularly important since mistakes or biases may affect patient safety and clinical decision-making. This article highlights healthcare AI-driven prediction model case studies and successes. These examples show how AI streamlines time-to-market, improves clinical results, and advances healthcare innovation. The study examines these case studies to identify best practices, lessons learnt, and future AI-based healthcare application development paths. In conclusion, AI-driven predictive models may accelerate clinical application development and implementation, changing healthcare. AI can improve patient outcomes and time-to-market via data analysis, personalised treatment, and quicker clinical trials. AI in healthcare must overcome data privacy, system integration, and model accuracy issues to reach its full potential. As technology advances, research and innovation will be essential to using AI-driven prediction models and altering healthcare.

View more >>

Uploded Document Preview